SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
SNP analysis has become an appealing and convenient method to study DNA sequence variations. The market is likely to notice a double digit growth rate as more microarrays with more DNA probes enter the market.
Whole genome SNP analysis will be the major growth driver for this market. Lower multiplexing products, part of clinical trials are likely to account for more of the growth. Drop in prices will further boost the market with increased demand and adoption rates. Affymetrix, Applied Biosystems (ABI) (Life Technologies), and Illumina are the major players in this market.